Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New screening tool could uncover thousands of undiagnosed lung cases

NCT ID NCT05654597

Diagnosis Sponsor: Groupe Hospitalier du Havre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a French version of the CAPTURE tool, which uses a short questionnaire and a peak flow breath test, to find people with undiagnosed obstructive lung disease (like COPD). Over 1,000 adults aged 40 and older who had not been diagnosed with asthma or COPD took part. The goal was to see how well the tool could identify those who actually had lung problems when checked with a portable spirometer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this tool could help doctors identify people with undiagnosed lung disease earlier, leading to faster treatment.
What could go wrong
The study was terminated early, so results may be incomplete. The tool may not work as well in real-world settings or for all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,002 people

The number who actually took part.

Started

Apr 2023

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult men and women over 40 years old will be recruited from a broad range of healthcare professional in primary care across the country. Any patient attending an appointment will be screened for inclusion.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * People aged 40 or more, * Provision of dated and signed informed consent form, * Currently being treated by a healthcare professional, * Patients affiliated to the french social security system. Exclusion Criteria: * Patients previously diagnosed with COPD or asthma, * Patients with any condition making them unable to perform spirometry or answer a short questionnaire, * Patients unable to give free and informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma chronic obstructive pulmonary disease lung disorder obstructive lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung diseases Lung diseases, obstructive Obstructive pulmonary disease

Contacts and locations

Locations

  • Groupe Hospitalier du Havre

    Le Havre, Normandy, 76600, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.